Funder
Norges Forskningsråd
South African Medical Research Council
Direktoratet for Utviklingssamarbeid
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. Human papillomavirus and related diseases in the world. Summary Report. 2017.
2. HPV vaccine communication. Special considerations for a unique vaccine: 2016 update. Geneva: World Health Organization; 2017.
3. Lee LA, Franzel L, Atwell J, Datta SD, Friberg IK, Goldie SJ, Reef SE, Schwalbe N, Simons E, Strebel PM, Sweet S, Suraratdecha C, Tam Y, Vynnycky E, Walker N, Walker DG, Hansen PM. The estimated mortality impact of vaccinations forecast to be administered during 2011–2020 in 73 countries supported by the GAVI Alliance. Vaccine. 2013;31:B61–72.
4. Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014;32(17):1901–20.
5. Fantom N, Serajuddin U. The World Bank’s classification of countries by Income: Data Group, Development Economics, World Bank Group; 2016.